DT4PCP: A Digital Twin Framework for Personalized Care Planning Applied to Type 2 Diabetes Management

Huanmei Wu; Javad M Alizadeh; Mukesh K Patel

REVIEW 4 major objections 4 minor 16 references

DT4PCP: A Digital Twin Framework for Personalized Care Planning Applied to Type 2 Diabetes Management

T0 review · 4 major / 4 minor · reviewed 2026-08-06 · deepseek-v4-flash

Challenge this review Re-run · record.json Download PDF Read on arXiv ↗ Review JSON

Pith's one-line read The paper claims that a digital-twin framework for personalized care planning, implemented for type 2 diabetes, can predict emergency department visits with an AUC of 0.82 and lets clinicians simulate changes in modifiable features to…

desk verdict A clear framework paper with a plausible AUC and a concrete GUI, but the 'simulate interventions' step is just feature perturbation on a fitted classifier, so the central promise is not supported; still worth a referee. read the letter →

arxiv 2507.07809 v2 pith:TYKEFZVC submitted 2025-07-10 q-bio.QM

Javad M Alizadeh , Mukesh K Patel , Huanmei Wu This is my paper · ORCID

classification q-bio.QM

keywords DigitaltwinType2diabetesEmergencydepartmentvisitpredictionPersonalizedcareplanningMachinelearningSocialdeterminantsofhealthClinicaldecisionsupport

verification ladder T0 review T1 audit T2 compute T3 formal

The pith

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The reading

The paper argues that a practical digital twin for chronic disease is feasible today: a real-time virtual representation of a patient, assembled from electronic health records, social determinants of health, vital signs, and behavioral data, can be paired with pretrained machine-learning classifiers to predict near-future emergency department visits. Applied to type 2 diabetes, the DT4PCP-T2D implementation reports an area under the ROC curve of 0.82 for its best models, identifies the features that drive risk, and embeds them in a graphical tool where a clinician can change adjustable values such as BMI or blood pressure, re-predict, and formulate personalized recommendations. The paper's larger claim is that this loop—predict, simulate, recommend, monitor—can make chronic disease management proactive and reduce avoidable emergency visits and healthcare costs. A sympathetic reader would care because the framework is presented as general, not diabetes-specific, and as a working prototype rather than a purely conceptual architecture.

What carries the argument

The central object is the DT4PCP framework—a digital twin for personalized care planning—defined as a continuously updated virtual representation of a patient's health that feeds pretrained predictive models and a simulation loop. In the T2D implementation the machinery consists of: retrospective data integration (electronic health records, social determinants, demographics, behavioral data) and dynamic real-time data; feature engineering that harmonizes ICD-9, ICD-10, and SNOMED-CT codes into 742 categories and selects the 30 most frequent diagnoses; six optimized classifiers evaluated by ten-fold cross-validation; and a GUI that treats diagnosis and vital-sign fields as adjustable, re-runs the classifier after edits, and surfaces SHAP-ranked risk factors. The claim-carrying step is the re-prediction loop in steps 8–10 of the workflow, where modifying a feature such as BMI or systolic blood pressure is treated as simulating an intervention.

What would settle it

Take a held-out cohort of T2D patients with naturally occurring changes in BMI, systolic blood pressure, or weight between two visits; for each patient, run the classifier once with the original values and once with the later values, and compare the predicted risk change against whether an ED visit actually occurred. If the simulated risk changes do not track realized outcomes—or track them no better than a model using baseline risk alone—the intervention-simulation claim is falsified.

Watch

Extended reading notes

Core claim

The central discovery is that six standard classifiers trained on a large regional cohort of 34,151 adults with type 2 diabetes can predict whether a patient will have an emergency department visit with an AUC of 0.82, with ensemble learning, random forest, and XGBoost performing best and balanced accuracy around 0.74. Feature-importance analysis shows that demographic factors, zip-code-level social determinants, frequent diagnoses such as abdominal pain, chest pain, nicotine dependence, and obesity, vital signs, and healthcare utilization gaps all contribute to risk. Around this predictive core the paper builds a digital-twin workflow: a GUI retrieves a patient's records, displays adjustable and non-adjustable features, ranks predictors by SHAP values, and lets a provider modify adjustable features and re-run the prediction until a personalized recommendation is reached. The authors present this as a demonstration that digital twins for personalized care planning can be implemented and evaluated retrospectively, with future work aimed at automating scenario generation, integrating wearables, and measuring long-term outcomes.

Load-bearing premise

The load-bearing premise is that changing an adjustable feature value in the GUI and re-running the fitted classifier tells a clinician what would happen if the patient actually changed that factor; this requires the observational training data to support a causal, unconfounded relationship between modifiable features and emergency department visits.

Editorial extensions

If this is right

The framework can flag high-risk patients from routinely collected data, without requiring new clinical tests.
The best-performing models (ensemble learning, random forest, XGBoost) reach an AUC of 0.82, making them usable for risk stratification in type 2 diabetes populations.
The GUI workflow gives providers a concrete way to test what-if changes in modifiable features before finalizing a care plan.
Integrating social determinants and visit-utilization patterns shifts recommendations beyond medication, toward socioeconomic and behavioral targets.
Periodic retraining and the iterative feedback loop let the model adapt as a patient's health state and data volume change.

Reading between the lines

Editorial extensions of the paper, not claims the author makes directly.

The 'simulation' in the GUI is not a causal simulation: re-running a fitted classifier on edited feature values estimates a counterfactual only if the model is unconfounded, which the paper does not establish; a stronger design would validate counterfactual predictions against a randomized encouragement or natural-experiment cohort.
The framework's most defensible near-term use is risk stratification and structured shared decision-making, rather than precise outcome prediction from hypothetical interventions.
Automating threshold search over feature ranges—flagged by the authors as future work—could turn the tool into a personalized decision-point finder, such as the BMI or systolic blood pressure value at which predicted ED risk crosses a clinical threshold.
Extending the framework to comorbid T2D plus hypertension or to streamed wearable data, as the paper suggests, will require re-validating both the prediction and the simulation claims; the current evidence supports only the T2D-only cohort.

Share X Bluesky LinkedIn Reddit HN

Signed reviews

No signed human review yet.

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, and a circularity audit.

Desk Editor's Note

read the letter

Two things to know. First, this is a competent health-informatics framework paper: it describes a GUI-based digital twin for T2D care planning, integrates SDoH data, and reports an AUC of 0.82 for predicting ED visits on a large retrospective cohort (34k patients). Second, the headline claim that clinicians can simulate interventions and thereby reduce ED visits is not supported by the evaluation; the simulation step is just changing feature values in the GUI and re-running the same fitted classifier.

What is actually new is the systems integration. The authors combine a pretrained ML model, a GUI, real-time data collection, and SDoH into a workflow a provider could plausibly use. The GUI walkthrough in Section 3.2 is concrete and gives a clear sense of how the tool is supposed to operate. The feature importance and SHAP plots are standard but helpful. The data scale is substantial: 76M encounters, 113M vital signs, harmonized ICD codes. They also honestly cite their own prior arXiv 2412.08984, which is appropriate since the predictive model appears to largely reuse that work.

The soft spots are real but not fatal for a conference paper. No confidence intervals, calibration, or external validation for the AUC. No baseline comparison like logistic regression to show the ML complexity buys anything. The intervention simulation assumes the observational model gives unconfounded estimates of changing BMI or SBP, which is a causal claim the paper never defends; the Discussion itself pushes this to future work ('automating the simulation phase'). I would also flag that they excluded all T2D patients with hypertension, a large and clinically relevant group, with no justification. The real-time dynamic data collection is described but not implemented or tested.

Who is this for: applied health informatics researchers and clinicians looking for a prototype of a DT-based care-planning tool. The predictive modeling itself won't teach an ML person anything new. It deserves a serious referee because the framework is clear, the data is real, and the flaws are fixable with language changes or an external validation. My recommendation: if this were under review, I would conditionally accept it, requiring the authors to either soften the causal claims or provide a proper causal analysis (target trial emulation, negative controls), and to report error bars. The core prediction story is fine; it is the 'simulation leads to reduced ED visits' claim that needs restraint.

Referee Report

4 major / 4 minor

Summary. The paper introduces DT4PCP, a general digital-twin framework for personalized chronic-disease care, and instantiates it for type 2 diabetes (DT4PCP-T2D). The implementation combines retrospective EHR data with real-time inputs, trains six machine-learning classifiers to predict binary emergency-department (ED) visits, and provides a GUI in which providers can modify adjustable features and re-run predictions to simulate interventions. On a dataset of 34,151 adults with T2D, the best models (Ensemble Learning, Random Forest, XGBoost) achieve an AUC of 0.82. The paper concludes that the framework can reduce avoidable ED visits and healthcare costs through proactive, personalized intervention simulation.

Significance. The manuscript is a concrete, working prototype rather than a purely conceptual proposal: it reports a large real-world dataset, a full pipeline from data harmonization to six ML models, and a usable GUI. The reported AUC of 0.82 is plausible for ED-visit risk stratification and the feature-importance analysis provides useful descriptive information. The strength of the paper is its end-to-end system description, which can serve as a reference architecture for others building digital-twin health applications. The central weakness is that the 'simulation of interventions' step is presented as a validated capability for reducing ED visits; in its current form it is merely a feature-perturbation exercise on an associational model, and the paper's own Discussion defers the outcome-based evaluation to future work. If the authors reframe the claims and add appropriate validation or clearly scope the simulation as hypothesis-generating, the contribution is a useful systems paper.

major comments (4)

[Section 3.2, steps 8–10] The intervention-simulation procedure is implemented by modifying feature values (e.g., BMI, SBP) and re-running the fitted classifier. This is not a causal estimate of the effect of weight-loss or antihypertensive therapy unless the model is unconfounded and correctly specified. The paper provides no causal identification strategy (e.g., target-trial emulation, g-computation, instrumental variables, negative controls), and the manuscript itself concedes in Section 4 that 'future research should assess the long-term impact on patient outcomes and healthcare costs.' The Abstract and Section 5 claim that the framework reduces avoidable ED visits; that claim is not supported by the reported evaluation and should either be removed or backed by external validation.
[Section 3.1] The reported AUC of 0.82 for EL, RF, and XGB is presented without confidence intervals, calibration curves, or external validation. The comparison among models is therefore not statistically grounded, and no baseline (e.g., logistic regression, published risk scores, or a simple frequency-based model) is reported. At minimum, the authors should provide bootstrap confidence intervals for all metrics and calibration plots, and ideally an external or temporally held-out cohort.
[Section 3.1 and Section 3.2] The prediction horizon for ED visits is never specified. The text refers to 'near-future' predictions, but the binary outcome is not defined with a time window (e.g., 30-day, 90-day, or 12-month ED visit). This ambiguity affects the interpretation of the AUC and the meaning of 'reducing avoidable ED visits'; the authors should state the outcome window explicitly and, if multiple horizons were tested, report results for each.
[Section 2.3] The description of personalization is vague. The paper states that 'the ML models are personalized based on the specific individual’s annotated data' and that models 'learn from these updated inputs using augmented methods,' but no algorithm, data volume requirement, or evaluation of personalization is provided. Because personalization is a core part of the digital-twin concept, the authors should either describe and evaluate this step or explicitly state that the current implementation only uses the pretrained population models with GUI-based input.

minor comments (4)

[Throughout] The manuscript contains several typographical and formatting issues, including the title rendering 'D IGITAL TWIN', the sentence 'future predictions With the pretrained models' in Section 2.3, and the duplicated headers. A careful proofread is needed.
[Section 3] The exclusion of patients with hypertension is not justified. Since hypertension is common in T2D and appears as a key feature in the model (SBP), excluding these patients may limit generalizability; the authors should explain the rationale or present sensitivity results.
[Section 3.1] The dataset description reports over 76 million medical encounters and 123 million diagnoses for 34,151 patients, but the final sample size after exclusions and the class balance (ED vs. non-ED) are not reported. This information is essential for interpreting the precision/recall trade-off.
[Section 2.3] The 'future predictions' paragraph is grammatically incomplete and contains a run-on structure that obscures the workflow. Rewriting this paragraph for clarity would help readers follow the iterative refinement process.

Circularity Check

1 steps flagged · score 6.0 of 10

ED-risk prediction is a genuine holdout result, but the intervention-simulation claim reduces by construction to re-running the fitted classifier on altered feature values.

fitted input called prediction [Section 3.2 (GUI workflow, steps 8-10); Section 4 (Discussion); Abstract]
"8. The provider can modify key feature values (e.g., BMI, SBP) in the GUI and click the 'PREDICT' button again to update the results. ... 10. Based on the updated results, the provider offers personalized recommendations (e.g., weight-loss program, dietary changes, antihypertensive therapy). ... Providers can use the GUI to simulate intervention outcomes before real-world implementation."

The intervention 'simulation' is performed by altering adjustable features in the GUI and re-running the same pretrained classifier from Section 3.1. The post-intervention risk is therefore, by construction, the classifier's output for the modified feature vector; the simulated effect is the difference between two predictions of the same observational model. No causal identification (e.g., target trial, g-computation, negative controls) or post-intervention outcome data is used, and the Discussion concedes 'automating the simulation phase' and 'long-term impact' remain future work. Thus the claimed ability to 'simulate the effects of different interventions' reduces to the fitted associations of the predictive model rather than to an independent estimate of intervention effect.

full rationale

The predictive-model evaluation (Section 3.1, AUC 0.82 on a 30% holdout with 10-fold cross-validation) is self-contained and not circular; it is a legitimate discriminative performance result. The circularity is confined to the framework's intervention-simulation claim. The GUI workflow (Section 3.2, steps 4-10) defines the predicted effect of an intervention as the change in the pretrained model's output after manually editing feature values such as BMI and SBP. That makes the asserted ability to 'simulate intervention outcomes' (Section 4) equivalent, by construction, to the model's own fitted input-output mapping. The Discussion further states that 'automating the simulation phase' and assessing 'long-term impact on patient outcomes and healthcare costs' are future work, confirming that the current simulation has no external causal validation. Score 6 reflects partial circularity: the risk-prediction component is independent, but the central simulation-and-reduction claim reduces to a re-run of the fitted model. No load-bearing self-citation was found; cited prior work is used contextually, not as a uniqueness or forcing argument.

Assumptions & free parameters 4 free parameters · 4 assumptions · 0 invented entities

The paper introduces no new physical or natural entities. The 'digital twin' is a software construct, not a new postulated phenomenon requiring independent falsifiable evidence outside the system.

free parameters (4)

Diagnosis feature count = 30
The number of diagnosis features was reduced to the 30 most frequent to mitigate overfitting (Section 3). This choice affects model performance and is data-dependent.
Train/test split = 70/30
Used for all models (Section 3.1); the split ratio is chosen without sensitivity analysis.
Prediction horizon for ED visits = unspecified
The paper says 'near-future' ED visits but never defines the time window, which is a key modeling choice for any predictive system.
Exclusion criteria = exclude hypertension, T1D, children
Patients with hypertension were excluded 'to enhance data validity' (Section 3), a post-hoc data selection that changes the target population and may bias generalizability.

assumptions (4)

domain assumption Retrospective EHR data can be used to train models that predict future ED visits
The entire pretrained-model step assumes historical patterns generalize forward in time (Section 2.2).
domain assumption Modifying features in the GUI and re-predicting estimates the effect of a real intervention
Steps 8-10 in Section 3.2 assume the classifier's counterfactual output is a valid simulation of clinical changes, which requires unconfoundedness and causal identification.
domain assumption Zip-code-level SDoH values represent individual social determinants
SDoH were linked to patients by zip code from ACS and SEDAC (Section 3), an ecological approximation that may misclassify individual circumstances.
standard math Standard 10-fold cross-validation gives unbiased performance estimates
Used in Section 3.1; a standard assumption in ML evaluation, but no repeated CV or CI is reported.

how reviews work

0 comments

Cite this review

Pith. "Pith review of DT4PCP: A Digital Twin Framework for Personalized Care Planning Applied to Type 2 Diabetes Management." pith.science (2026). https://pith.science/paper/TYKEFZVC

@misc{pith2026250707809,
  author       = {Pith},
  title        = {Pith review of: DT4PCP: A Digital Twin Framework for Personalized Care Planning Applied to Type 2 Diabetes Management},
  year         = {2026},
  howpublished = {\url{https://pith.science/paper/TYKEFZVC}},
  note         = {Machine review of arXiv:2507.07809}
}

read the original abstract

Digital Twin (DT) technology has emerged as a transformative approach in healthcare, but its application in personalized patient care remains limited. This paper aims to present a practical implementation of DT in the management of chronic diseases. We introduce a general DT framework for personalized care planning (DT4PCP), with the core components being a real-time virtual representation of a patient's health and emerging predictive models to enable adaptive, personalized care. We implemented the DT4PCP framework for managing Type 2 Diabetes (DT4PCP-T2D), enabling real-time collection of behavioral data from patients with T2D, predicting emergency department (ED) risks, simulating the effects of different interventions, and personalizing care strategies to reduce ED visits. The DT4PCP-T2D also integrates social determinants of health (SDoH) and other contextual data, offering a comprehensive view of the patient's health to ensure that care recommendations are tailored to individual needs. Through retrospective simulations, we demonstrate that integrating DTs in T2D management can lead to significant advancements in personalized medicine. This study underscores the potential of DT technology to revolutionize chronic disease care.

Figures

Figures reproduced from arXiv: 2507.07809 by the authors.

**Figure 1.** Digital Twin Framework. individual needs [12]. This shift enables healthcare providers to transition from reactive treatment to proactive disease management, thereby reducing avoidable ED visits and improving long-term patient outcomes. Recent studies show that DT-driven treatment can improve blood sugar control, lower HbA1c levels, and promote adherence to treatment plans, resulting in fewer diabetes-related compli… view at source ↗

**Figure 2.** The Receiver Operator Characteristic (ROC) [PITH_FULL_IMAGE:figures/full_fig_p004_2.png] view at source ↗

**Figure 4.** An illustration of the graphical user interface demonstrating its main features. [PITH_FULL_IMAGE:figures/full_fig_p005_4.png] view at source ↗

Discussion (0). Continue with ORCID to comment.

Reference graph

Works this paper leans on

16 extracted references · 16 canonical work pages

[1]

Type 2 diabetes in latin america and the caribbean: Regional and country comparison on prevalence, trends, costs and expanded prevention,

H. Gallardo-Rincón, A. Cantoral, A. Arrieta, C. Espinal, M. H. Magnus, C. Palacios, and R. Tapia-Conyer, “Type 2 diabetes in latin america and the caribbean: Regional and country comparison on prevalence, trends, costs and expanded prevention,” Primary Care Diabetes, vol. 15, no. 2, pp. 352–359, 2021

work page 2021
[2]

Geographically weighted machine learning model for untangling spatial heterogeneity of type 2 diabetes mellitus (t2d) prevalence in the usa,

S. Quiñones, A. Goyal, and Z. U. Ahmed, “Geographically weighted machine learning model for untangling spatial heterogeneity of type 2 diabetes mellitus (t2d) prevalence in the usa,”Scientific reports, vol. 11, no. 1, p. 6955, 2021

work page 2021
[3]

Trends in prevalence of type 1 and type 2 diabetes in children and adolescents in the us, 2001-2017,

J. M. Lawrence, J. Divers, S. Isom, S. Saydah, G. Imperatore, C. Pihoker, S. M. Marcovina, E. J. Mayer-Davis, R. F. Hamman, L. Dolan et al., “Trends in prevalence of type 1 and type 2 diabetes in children and adolescents in the us, 2001-2017,” Jama, vol. 326, no. 8, pp. 717–727, 2021

work page 2001
[4]

Predicting Emergency Department Visits for Patients with Type II Diabetes

J. M. Alizadeh, J. S. Patel, G. Tajeu, Y . Chen, I. L. Hollin, M. K. Patel, J. Fei, and H. Wu, “Predicting emergency department visits for patients with type II diabetes,” arXiv.org, December 12 2024. [Online]. Available: https://arxiv.org/abs/2412.08984

work page Pith review arXiv 2024
[5]

Prevalence of type 2 diabetes in psychiatric disorders: an umbrella review with meta-analysis of 245 observational studies from 32 systematic reviews,

N. Lindekilde, S. H. Scheuer, F. Rutters, L. Knudsen, M. Lasgaard, K. H. Rubin, J. E. Henriksen, M. Kivimäki, G. S. Andersen, and F. Pouwer, “Prevalence of type 2 diabetes in psychiatric disorders: an umbrella review with meta-analysis of 245 observational studies from 32 systematic reviews,”Diabetologia, pp. 1–17, 2022

work page 2022
[6]

American association of clinical endocrinology consensus statement: comprehensive type 2 diabetes management algorithm–2023 update,

S. L. Samson, P. Vellanki, L. Blonde, E. A. Christofides, R. J. Galindo, I. B. Hirsch, S. D. Isaacs, K. E. Izuora, C. C. L. Wang, C. L. Twining et al., “American association of clinical endocrinology consensus statement: comprehensive type 2 diabetes management algorithm–2023 update,” Endocrine Practice, vol. 29, no. 5, pp. 305–340, 2023

work page 2023
[7]

Implementation of a personalized care plan for patients with type 2 diabetes is associated with improvements in clinical outcomes: an observational real-world study,

A. Vuohijoki, I. Mikkola, J. Jokelainen, S. Keinänen-Kiukaanniemi, K. Winell, L. Frittitta, M. Timonen, and M. Hagnäs, “Implementation of a personalized care plan for patients with type 2 diabetes is associated with improvements in clinical outcomes: an observational real-world study,”Journal of Primary Care & Community Health, vol. 11, p. 2150132720921700, 2020

work page 2020
[8]

A personalized care plan is positively associated with better clinical outcomes in the care of patients with type 2 diabetes: a cross-sectional real-life study,

I. Mikkola, M. Hagnäs, J. Hartsenko, M. Kaila, and K. Winell, “A personalized care plan is positively associated with better clinical outcomes in the care of patients with type 2 diabetes: a cross-sectional real-life study,” Canadian journal of diabetes, vol. 44, no. 2, pp. 133–138, 2020

work page 2020

Show all 16 references

[9]

Mikkola, S

I. Mikkola, S. Morgan, K. Winell, J. Jokelainen, L. Frittitta, E. Heikkala, and M. Hagnäs, “Association of personalised care plans with monitoring and control of clinical outcomes, prescription of medication and utilisation of primary care services in patients with type 2 diab...

2022
[10]

Digital twins for health: A scoping review,

E. Katsoulakis, Q. Wang, H. Wu, L. Shahriyari, R. Fletcher, J. Liu, L. Achenie, H. Liu, P. Jackson, Y . Xiao, T. Syeda-Mahmood, R. Tuli, and J. Deng, “Digital twins for health: A scoping review,” npj Digital Medicine, vol. 7, no. 1, 2024

2024
[11]

A framework towards digital twins for type 2 diabetes,

Y . Zhang, G. Qin, B. Aguilar, N. Rappaport, J. T. Yurkovich, L. Pflieger, S. Huang, L. Hood, and I. Shmulevich, “A framework towards digital twins for type 2 diabetes,”Frontiers in Digital Health, vol. 6, 2024

2024
[12]

Envisioning the future of personalized medicine: Role and realities of digital twins,

A. Vallée, “Envisioning the future of personalized medicine: Role and realities of digital twins,” Journal of Medical Internet Research, vol. 26, p. e50204, 2024

2024
[13]

One-year outcomes of a digital twin intervention for type 2 diabetes: A retrospective real-world study,

P. Shamanna, R. S. Erukulapati, A. Shukla, L. Shah, B. Willis, M. Thajudeen, R. Kovil, R. Baxi, M. Wali, S. Damodharan, and S. Joshi, “One-year outcomes of a digital twin intervention for type 2 diabetes: A retrospective real-world study,”Scientific Reports, vol. 14, no. 1, 2024

2024
[14]

Personalized diabetes management with digital twins: A patient-centric knowledge graph approach,

F. S. Rad, R. Hendawi, X. Yang, and J. Li, “Personalized diabetes management with digital twins: A patient-centric knowledge graph approach,” Journal of Personalized Medicine, vol. 14, no. 4, p. 359, 2024. 7 Digital Twin for T2D Management A PREPRINT

2024
[15]

Digital twins: The new frontier for personalized medicine?

M. Cellina, M. Cè, M. Alì, G. Irmici, S. Ibba, E. Caloro, D. Fazzini, G. Oliva, and S. Papa, “Digital twins: The new frontier for personalized medicine?” Applied Sciences, vol. 13, no. 13, p. 7940, 2023

2023
[16]

Reducing hba1c in type 2 diabetes using digital twin technology-enabled precision nutrition: A retrospective analysis,

P. Shamanna, B. Saboo, S. Damodharan, J. Mohammed, M. Mohamed, T. Poon, N. Kleinman, and M. Thajudeen, “Reducing hba1c in type 2 diabetes using digital twin technology-enabled precision nutrition: A retrospective analysis,” Diabetes Therapy, vol. 11, no. 11, pp. 2703–2714, 2020. 8

2020

Pith tools

Reviewed August 6, 2026 · model on record in the stance chip above.

[1] [1]

Type 2 diabetes in latin america and the caribbean: Regional and country comparison on prevalence, trends, costs and expanded prevention,

H. Gallardo-Rincón, A. Cantoral, A. Arrieta, C. Espinal, M. H. Magnus, C. Palacios, and R. Tapia-Conyer, “Type 2 diabetes in latin america and the caribbean: Regional and country comparison on prevalence, trends, costs and expanded prevention,” Primary Care Diabetes, vol. 15, no. 2, pp. 352–359, 2021

work page 2021

[2] [2]

Geographically weighted machine learning model for untangling spatial heterogeneity of type 2 diabetes mellitus (t2d) prevalence in the usa,

S. Quiñones, A. Goyal, and Z. U. Ahmed, “Geographically weighted machine learning model for untangling spatial heterogeneity of type 2 diabetes mellitus (t2d) prevalence in the usa,”Scientific reports, vol. 11, no. 1, p. 6955, 2021

work page 2021

[3] [3]

Trends in prevalence of type 1 and type 2 diabetes in children and adolescents in the us, 2001-2017,

J. M. Lawrence, J. Divers, S. Isom, S. Saydah, G. Imperatore, C. Pihoker, S. M. Marcovina, E. J. Mayer-Davis, R. F. Hamman, L. Dolan et al., “Trends in prevalence of type 1 and type 2 diabetes in children and adolescents in the us, 2001-2017,” Jama, vol. 326, no. 8, pp. 717–727, 2021

work page 2001

[4] [4]

Predicting Emergency Department Visits for Patients with Type II Diabetes

J. M. Alizadeh, J. S. Patel, G. Tajeu, Y . Chen, I. L. Hollin, M. K. Patel, J. Fei, and H. Wu, “Predicting emergency department visits for patients with type II diabetes,” arXiv.org, December 12 2024. [Online]. Available: https://arxiv.org/abs/2412.08984

work page Pith review arXiv 2024

[5] [5]

Prevalence of type 2 diabetes in psychiatric disorders: an umbrella review with meta-analysis of 245 observational studies from 32 systematic reviews,

N. Lindekilde, S. H. Scheuer, F. Rutters, L. Knudsen, M. Lasgaard, K. H. Rubin, J. E. Henriksen, M. Kivimäki, G. S. Andersen, and F. Pouwer, “Prevalence of type 2 diabetes in psychiatric disorders: an umbrella review with meta-analysis of 245 observational studies from 32 systematic reviews,”Diabetologia, pp. 1–17, 2022

work page 2022

[6] [6]

American association of clinical endocrinology consensus statement: comprehensive type 2 diabetes management algorithm–2023 update,

S. L. Samson, P. Vellanki, L. Blonde, E. A. Christofides, R. J. Galindo, I. B. Hirsch, S. D. Isaacs, K. E. Izuora, C. C. L. Wang, C. L. Twining et al., “American association of clinical endocrinology consensus statement: comprehensive type 2 diabetes management algorithm–2023 update,” Endocrine Practice, vol. 29, no. 5, pp. 305–340, 2023

work page 2023

[7] [7]

Implementation of a personalized care plan for patients with type 2 diabetes is associated with improvements in clinical outcomes: an observational real-world study,

A. Vuohijoki, I. Mikkola, J. Jokelainen, S. Keinänen-Kiukaanniemi, K. Winell, L. Frittitta, M. Timonen, and M. Hagnäs, “Implementation of a personalized care plan for patients with type 2 diabetes is associated with improvements in clinical outcomes: an observational real-world study,”Journal of Primary Care & Community Health, vol. 11, p. 2150132720921700, 2020

work page 2020

[8] [8]

A personalized care plan is positively associated with better clinical outcomes in the care of patients with type 2 diabetes: a cross-sectional real-life study,

I. Mikkola, M. Hagnäs, J. Hartsenko, M. Kaila, and K. Winell, “A personalized care plan is positively associated with better clinical outcomes in the care of patients with type 2 diabetes: a cross-sectional real-life study,” Canadian journal of diabetes, vol. 44, no. 2, pp. 133–138, 2020

work page 2020